Do Client Attributes Moderate the Effectiveness of a Group Cognitive Behavioral Therapy for Depression in Addiction Treatment?

  • Sarah B. Hunter
  • Susan M. Paddock
  • Annie Zhou
  • Katherine E. Watkins
  • Kimberly A. Hepner
Article

Abstract

The study goal was to determine whether client attributes were associated with outcomes from group cognitive behavioral therapy for depression (GCBT-D) as delivered in community-based addiction treatment settings. Data from 299 depressed residential clients assigned to receive either usual care (N = 159) or usual care plus GCBT-D (N = 140) were examined. Potential moderators included gender, race/ethnicity, education, referral status, and problem substance use. Study outcomes at 6 months post-baseline included changes in depressive symptoms, mental health functioning, negative consequences from substance use, and percentage of days abstinent. Initial examination indicated that non-Hispanic Whites had significantly better outcomes than other racial/ethnic groups on two of the four outcomes. After correcting for multiple testing, none of the examined client attributes moderated the treatment effect. GCBT-D appears effective; however, the magnitude and consistency of treatment effects indicate that it may be less helpful among members of racial/ethnic minority groups and is worthy of future study.

References

  1. 1.
    Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003; 289(23):3095-3105.PubMedCrossRefGoogle Scholar
  2. 2.
    Marlatt GA, Gordon JR (Eds). Relapse Prevention: Maintenance Strategies in Addictive Behavior Change. New York: Guilford, 1985.Google Scholar
  3. 3.
    Witkiewitz K, Villarroel NA. Dynamic association between negative affect and alcohol lapses following alcohol treatment. Journal of Consulting and Clinical Psychology 2009; 77(4):633-644.PubMedCrossRefGoogle Scholar
  4. 4.
    Brown SA, Glasner-Edwards SV, Tate SR, et al. Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders. Journal of Psychoactive Drugs 2006; 38(4):449-460.PubMedCrossRefGoogle Scholar
  5. 5.
    Lydecker KP, Tate SR, Cummins KM, et al. Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors 2010; 24(3):453-465.PubMedCrossRefGoogle Scholar
  6. 6.
    Watkins KE, Hunter SB, Hepner KA, et al. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment. Archives of General Psychiatry 2011; 68(6):577-584.PubMedCrossRefGoogle Scholar
  7. 7.
    Hoff RA, Rosenheck RA. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services 1999; 50(10):1309-1315.PubMedGoogle Scholar
  8. 8.
    Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002; 59(10):877-883.PubMedCrossRefGoogle Scholar
  9. 9.
    La Greca AM, Silverman WK, Lochman JE. Moving beyond efficacy and effectiveness in child and adolescent intervention research. Journal of Consulting and Clinical Psychology 2009; 77(3):373-382.PubMedCrossRefGoogle Scholar
  10. 10.
    Brown RA, Evans DM, Miller IW, et al. Cognitive-behavioral treatment for depression in alcoholism. Journal of Consulting and Clinical Psychology 1997; 65(5):715-726.PubMedCrossRefGoogle Scholar
  11. 11.
    Baker AL, Kavanagh DJ, Kay-Lambkin FJ, et al. Randomized controlled trial of cognitive–behavioural therapy for coexisting depression and alcohol problems: Short-term outcome. Addiction 2010; 105(1):87-99.PubMedCrossRefGoogle Scholar
  12. 12.
    Watkins KE, Hunter S, Hepner K, et al. Group cognitive behavioral therapy for clients with major depression in residential substance abuse treatment. Psychiatric Services 2012; 63(6):608-611.PubMedCrossRefGoogle Scholar
  13. 13.
    Minkoff K, Cline CA. Changing the world: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders. The Psychiatric clinics of North America 2004; 27(4):727-743.PubMedCrossRefGoogle Scholar
  14. 14.
    Kraemer HC, Frank E, Kupfer DJ. Moderators of treatment outcomes: Clinical, research, and policy importance. Journal of the American Medical Association 2006; 296(10):1286-1289.PubMedCrossRefGoogle Scholar
  15. 15.
    Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine—Reporting of subgroup analyses in clinical trials. New England Journal of Medicine 2007; 357(21):2189-2194.PubMedCrossRefGoogle Scholar
  16. 16.
    Cuzick J. Forest plots and the interpretation of subgroups. Lancet 2005; 365(9467):1308.PubMedCrossRefGoogle Scholar
  17. 17.
    Miranda J, Bernal G, Lau A, et al. State of the science on psychosocial interventions for ethnic minorities. Annual Review of Clinical Psychology 2005; 1:113-142.PubMedCrossRefGoogle Scholar
  18. 18.
    Organista KC, Munoz, Ricardo F. Gonzalez, Gerardo. Cognitive–behavioral therapy for depression in low-income and minority medical outpatients: Description of a program and exploratory analyses. Cognitive Therapy and Research 1994; 18 3:241-259CrossRefGoogle Scholar
  19. 19.
    Martin SS, Butzin CA, Saum CA, et al. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare. The Prison Journal 1999; 79(3):294-320.CrossRefGoogle Scholar
  20. 20.
    Prendergast ML, Wellisch J, Wong MM. Residential treatment for women parolees following prison-based drug treatment: Treatment experiences, needs and services, outcomes. The Prison Journal 1996; 76(3):253-274.CrossRefGoogle Scholar
  21. 21.
    Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: Similarities and dissimilarities. Addiction 1994; 89(11):1461-1470.PubMedCrossRefGoogle Scholar
  22. 22.
    Lago JA, Kosten TR. Stimulant withdrawal. Addiction 1994; 89(11):1477-1481.PubMedCrossRefGoogle Scholar
  23. 23.
    West R, Gossop M. Overview: A comparison of withdrawal symptoms from different drug classes. Addiction 1994; 89(11):1483-1489.PubMedCrossRefGoogle Scholar
  24. 24.
    Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. Journal of the American Medical Association 1999; 282:1737-1744.PubMedCrossRefGoogle Scholar
  25. 25.
    Beck A, Steer R, Brown G. BDI-II, Beck Depression Inventory: Manual, Second Edition. Boston: Harcourt Brace, 1996.Google Scholar
  26. 26.
    Buckley TC, Parker JD, Heggie J. A psychometric evaluation of the BDI-II in treatment-seeking substance abusers. Journal of Substance Abuse Treatment 2001; 20(3):197-204.PubMedCrossRefGoogle Scholar
  27. 27.
    Sloan K, Kivlahan D, Saxon A. Detecting bipolar disorder among treatment-seeking substance abusers. The American Journal of Drug and Alcohol Abuse 2000 26(1):13-23.PubMedCrossRefGoogle Scholar
  28. 28.
    Wells K, Sturm R, Burnam M. Healthcare for Communities (HCC) Psychoticism screener. Healthcare for Communities HCC1 Questionnaire. Available from: http://www.hsrcenter.ucla.edu/research/hcc.shtml
  29. 29.
    Dennis ML, White MK, Titus JC, et al. Short blessed scale exam. Global appraisal of individual needs: Trainer’s training manual and resources (July 2006 version). Bloomington, IL: Chestnut Health Systems, 2006Google Scholar
  30. 30.
    Muñoz R, Ippen C, Rao S, et al. Manual for group cognitive–behavioral therapy of major depression: A reality management approach. Cognitive Behavioral Depression Clinic, San Francisco General Hospital, University of California, San Francisco; 2000.Google Scholar
  31. 31.
    Muñoz RF, Mendelson T. Toward evidence-based interventions for diverse populations: The San Francisco General Hospital prevention and treatment manuals. Journal of Consulting and Clinical Psychology 2005; 73(5):790-799.PubMedCrossRefGoogle Scholar
  32. 32.
    Hepner KA, Miranda JM, Woo SM, et al. Building Recovery by Improving Goals, Habits, and Thoughts (BRIGHT): A Group Cognitive Behavioral Therapy for Depression in Clients with Co-Occurring Alcohol and Drug Use Problems—Group Leader’s Manual. Santa Monica, CA: RAND Corporation, 2011.Google Scholar
  33. 33.
    Hepner KA, Hunter SB, Paddock SM, et al. Training addiction counselors to implement CBT for depression. Administration and Policy in Mental Health and Mental Health Services Research 2011; 38:313–323.PubMedCrossRefGoogle Scholar
  34. 34.
    Hepner KA, Stern S, Paddock SM, et al. A fidelity coding guide for a group cognitive behavioral therapy for depression. Santa Monica, CA: RAND Corporation, 2011.Google Scholar
  35. 35.
    McLellan A, Carise D, Coyne T. Addiction Severity Index (ASI), Fifth Edition. Philadelphia, PA: Treatment Research Institute, 2005.Google Scholar
  36. 36.
    Ware J, Jr., Kosinski M, Turner-Bowker D, et al. How to Score Version 2 of the SF-12® Health Survey (with a Supplement Documenting Version 1). Lincoln, RI: Quality Metric Incorporated, 2002.Google Scholar
  37. 37.
    Tonigan JS, Miller WR. The Inventory of Drug Use Consequences (InDUC): Test–retest stability and sensitivity to detect change. Psychology of Addictive Behaviors 2002; 16(2):165-168.PubMedCrossRefGoogle Scholar
  38. 38.
    Sobell LC, Sobell MB. Alcohol Timeline Followback Users’ Manual. Toronto: Addiction Research Foundation, 1995.Google Scholar
  39. 39.
    Cohen J. Statistical Power Analysis for the Behavioral Sciences, Second Edition. New York: Routledge Academic, 1988.Google Scholar
  40. 40.
    Carey K. A multilevel modeling approach to analysis of patient costs under managed care. Health Economics 2000; 9:435–446.PubMedCrossRefGoogle Scholar
  41. 41.
    Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 1995; 57(1):289-300.Google Scholar
  42. 42.
    McKay JR, Lynch KG, Shepard DS, et al. Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders? Addiction 2005; 100(2):216-226.PubMedCrossRefGoogle Scholar
  43. 43.
    Zerhouni E. NIH at the Crossroads: Strategies for the Future. Paper presented at the National Advisory Mental Health Council, 213th Meeting, Rockville, MD, September 14-15, 2006.Google Scholar
  44. 44.
    Kraemer HC. Toward non-parametric and clinically meaningful moderators and mediators. Statistics in Medicine 2008; 27(10):1679-1692.PubMedCrossRefGoogle Scholar
  45. 45.
    Marsh JC, Cao D, Guerrero E, et al. Need-service matching in substance abuse treatment: Racial/ethnic differences. Evaluation and Program Planning 2009; 32(1):43-51.PubMedCrossRefGoogle Scholar
  46. 46.
    Alegria M, Page JB, Hansen H, et al. Improving drug treatment services for Hispanics: Research gaps and scientific opportunities. Drug and Alcohol Dependence 2006; 84 S:S76-S84.CrossRefGoogle Scholar
  47. 47.
    Alvarez J, Olson BD, Jason LA, et al. Heterogeneity among Latinas and Latinos entering substance abuse treatment: Findings from a national database. Journal of Substance Abuse Treatment 2004; 26(4):277-284.PubMedCrossRefGoogle Scholar
  48. 48.
    Buka SL. Disparities in health status and substance use: Ethnicity and socioeconomic factors. Public Health Reports 2002; 117 Suppl 1:S118-125.PubMedGoogle Scholar
  49. 49.
    Niv N, Pham R, Hser YI. Racial and ethnic differences in substance abuse service needs, utilization, and outcomes in California. Psychiatric Services 2009; 60(10):1350-1356.PubMedCrossRefGoogle Scholar
  50. 50.
    Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 2005. Discharges from Substance Abuse Treatment Services. Rockville, MD: DHHS Publication No. (SMA) 08-4314, 2008.Google Scholar
  51. 51.
    Karno MP, Beutler LE, Harwood TM. Interactions between psychotherapy procedures and patient attributes that predict alcohol treatment effectiveness: A preliminary report. Addictive Behaviors 2002; 27(5):779-797.PubMedCrossRefGoogle Scholar
  52. 52.
    Rosenblum A, Foote J, Cleland C, et al. Moderators of effects of motivational enhancements to cognitive behavioral therapy. American Journal of Drug and Alcohol Abuse 2005; 31(1):35-58.PubMedGoogle Scholar

Copyright information

© National Council for Community Behavioral Healthcare 2012

Authors and Affiliations

  • Sarah B. Hunter
    • 1
  • Susan M. Paddock
    • 1
  • Annie Zhou
    • 1
  • Katherine E. Watkins
    • 1
  • Kimberly A. Hepner
    • 1
  1. 1.RAND, Drug Policy Research CenterSanta MonicaUSA

Personalised recommendations